C42H48N6O11 — CID 118045754
2-methoxy-3-[4-[[5-[[4-(5-methoxycarbonyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylpyrrol-3-yl]amino]-4-oxobutoxy]-6-(oxan-2-yloxy)-11-oxo-6a,7,8,9-tetrahydro-6H-pyrrolo[2,1-c][1,4]benzodiazepine-5-carboxylic acid (PubChem CID 118045754) has the molecular formula C42H48N6O11 and a molecular weight of 812.88 g/mol. Its IUPAC name is 2-methoxy-3-[4-[[5-[[4-(5-methoxycarbonyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylpyrrol-3-yl]amino]-4-oxobutoxy]-6-(oxan-2-yloxy)-11-oxo-6a,7,8,9-tetrahydro-6H-pyrrolo[2,1-c][1,4]benzodiazepine-5-carboxylic acid.
| Compound Name | 2-methoxy-3-[4-[[5-[[4-(5-methoxycarbonyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylpyrrol-3-yl]amino]-4-oxobutoxy]-6-(oxan-2-yloxy)-11-oxo-6a,7,8,9-tetrahydro-6H-pyrrolo[2,1-c][1,4]benzodiazepine-5-carboxylic acid |
|---|---|
| PubChem CID | 118045754 |
| Molecular Formula | C42H48N6O11 |
| Molecular Weight | 812.88 g/mol |
| Exact Mass | 812.34 |
| IUPAC Name | 2-methoxy-3-[4-[[5-[[4-(5-methoxycarbonyl-1-methylpyrrol-3-yl)phenyl]carbamoyl]-1-methylpyrrol-3-yl]amino]-4-oxobutoxy]-6-(oxan-2-yloxy)-11-oxo-6a,7,8,9-tetrahydro-6H-pyrrolo[2,1-c][1,4]benzodiazepine-5-carboxylic acid |
| SMILES | COC(=O)c1cc(-c2ccc(NC(=O)c3cc(NC(=O)CCCOc4cc5c(cc4OC)C(=O)N4CCCC4C(OC4CCCCO4)N5C(=O)O)cn3C)cc2)cn1C |
| InChI | InChI=1S/C42H48N6O11/c1-45-23-26(19-33(45)41(52)56-4)25-12-14-27(15-13-25)44-38(50)32-20-28(24-46(32)2)43-36(49)10-8-18-57-35-22-31-29(21-34(35)55-3)39(51)47-16-7-9-30(47)40(48(31)42(53)54)59-37-11-5-6-17-58-37/h12-15,19-24,30,37,40H,5-11,16-18H2,1-4H3,(H,43,49)(H,44,50)(H,53,54) |
| InChIKey | GSHNLDHTDWQBRX-UHFFFAOYSA-N |
| XLogP | 5.85 |
| TPSA | 192.13 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 59 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 812.88 |
| LogP ≤ 5 | 5.85 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 12 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|